Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Neuropharmacology. 2019 Jun 4;158:107662. doi: 10.1016/j.neuropharm.2019.06.001

Figure 1.

Figure 1.

A candidate vaccine targeting oxycodone and hydrocodone use disorders. The oxycodone-based hapten [OXY(Gly)4] is conjugated to the keyhole limpet hemocyanin (KLH) carrier protein and adsorbed on adjuvant. Immunization with OXY-KLH reduced oxycodone-induced behavioral, pharmacological and toxic effects in mice and rats.